Insider · CIK 0001826452
Thomas Ronan Kennedy
Files at YCBD (cbdMD, Inc.). First filing -, latest -.
In brief
Thomas Ronan Kennedy files SEC Form 4 as CEO, CFO and director at YCBD (cbdMD, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Thomas Ronan Kennedy has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 28, 2025 | YCBD cbdMD, Inc. | AGrant or award Common Stock | +445,000 | - | - | 513,722 | Dec 2, 2025 |
| May 6, 2025 | YCBD cbdMD, Inc. | CConversion Common Stock | +67,869 | - | - | 74,501 | May 8, 2025 |
| May 6, 2025 | YCBD cbdMD, Inc. | CConversion 8% Series A Cumulative Convertible Preferred Stockderivative | -41,765 | - | - | 0 | May 8, 2025 |
Questions about Thomas Ronan Kennedy
Answered from the filings on this page, as of the latest one.
Is Thomas Ronan Kennedy buying or selling?
Thomas Ronan Kennedy has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Thomas Ronan Kennedy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas Ronan Kennedy has 0.
Where does Thomas Ronan Kennedy file Form 4?
Thomas Ronan Kennedy has filed Form 4 at YCBD (cbdMD, Inc.) as CEO and CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.